ORBIMED ADVISORS LLC Insider Trading $ANTH Anthera Pharmaceuticals Inc
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is Director in AMARIN CORP PLC\UK ($AMRN) and 10% Owner in AMBIT BIOSCIENCES CORP ($AMBI) and 10% Owner in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Anthera Pharmaceuticals Inc ($ANTH) and 10% Owner in COMPLETE GENOMICS INC ($GNOM) and 10% Owner in Pacira Pharmaceuticals, Inc. ($PCRX) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Mirati Therapeutics, Inc. ($MYG).
ORBIMED ADVISORS LLC in Anthera Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 7,462,000 shares
Current Value: $4,402,580
Latest Transaction: Feb 01 2013
$ANTH Market Capitalization: $23.84M
$ANTH Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in Anthera Pharmaceuticals Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRN, AMBI, ANTH, GNOM, ICPT, MYG, PCRX, RLYP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 01 2013 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Buy | P | 0.66 | 5,700,000 | 3,762,000 | 7,462,000 | 1.8 M to 7.5 M (+323.50 %) |
| Jan 29 2013 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Buy | P | 0.65 | 1,762,000 | 1,142,481 | 1,762,000 | 0 to 1.8 M |
| Jul 03 2012 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Sell | S | 0.73 | 1,283,300 | 942,071 | 0 | 1.3 M to 0 (-100.00 %) |
| Mar 22 2012 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Sell | S | 2.40 | 1,306,700 | 3,140,131 | 1,283,300 | 2.6 M to 1.3 M (-50.45 %) |
| Mar 22 2012 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Sell | S | 2.87 | 125,000 | 358,313 | 2,590,000 | 2.7 M to 2.6 M (-4.60 %) |
| Mar 22 2012 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Sell | S | 2.90 | 116,800 | 338,638 | 2,715,000 | 2.8 M to 2.7 M (-4.12 %) |
Page: 1